Evidence map›Paper›PMID 29085236›Full record

ArticleWorld journal of gastroenterology2017

Resistance of

Mohammad Zamani, Arash Rahbar, Javad Shokri-Shirvani

Open access · hybridAbstract readComment
In one paragraph

Article in World journal of gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Effectiveness of Susceptibility-Guided Therapy forInfection and drug resistance · 2025
    Article
  5. Article
  6. Helicobacter pylori infection.Nature reviews. Disease primers · 2023
    Review
  7. Review
  8. A Survey ofAntimicrobial agents and chemotherapy · 2022
    Article
  9. Study on the value of antibiotic-resistant gene detection inExperimental and therapeutic medicine · 2022
    Article
  10. Article
  11. Journal of medical microbiology · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Mohammad ZamaniStudent Research Committee, Babol University of Medical Sciences, Babol 47176-47745, Iran.
Arash RahbarStudent Research Committee, Babol University of Medical Sciences, Babol 47176-47745, Iran.
Javad Shokri-ShirvaniDepartment of Internal Medicine, Babol University of Medical Sciences, Babol 47176-47745, Iran. j.shokri@mubabol.ac.ir.
Babol University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In their review, Arslan et al

Indexed as

FurazolidoneLevofloxacinAsiaDrug Resistance, BacterialEuropeHelicobacter InfectionsHelicobacter pyloriMicrobial Sensitivity TestsFurazolidoneLevofloxacinFurazolidoneHelicobacter pyloriLevofloxacinResistanceSusceptibilityTreatment

Identifiers

PMID29085236
PMCPMC5645626
OpenAlexW2760747448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.